Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?

21 Sept 2022

Abstract excerpt

Coronavirus Disease 2019 (COVID-19) has plagued the world throughout 2020 to 2022, with over 580 million confirmed cases and 6.4 million deaths.Several vaccines have been approved for human use, including those from Pfizer-BioNTech, Moderna, Novavax, AstraZeneca, Johnson & Johnson, and Sinovac.The focus on rapid vaccine platforms such as mRNA, adenovirus vectors, DNA vectors, inactivated and subunit vaccines for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Long-Term Effects of COVID-19
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36129963
DOI: 10.1371/journal.ppat.1010821

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?PMID 36129963Read ↗

Vaccines platforms and COVID-19: what you need to knowSemantic proximity Read ↗

COVID-19 Vaccines: Where Do We Stand at the End of 2023?Semantic proximity Read ↗

SARS-CoV-2 vaccines - the biggest medical research project of the 21st century.Semantic proximity Read ↗

COVID-19 vaccination is highly effective to prevent SARS-CoV-2 circulationSemantic proximity Read ↗

COVID-19 vaccinations: The unknowns, challenges, and hopes.Semantic proximity Read ↗

Effectiveness of COVID‑19 vaccines and their challenges (Review)Semantic proximity Read ↗

SARS-CoV-2 Variants and Vaccines.Semantic proximity Read ↗

Vaccine Approaches for Pandemic COVID-19Semantic proximity Read ↗

Prophylactic domain-based vaccine against SARS-CoV-2, causative agent of COVID-19 pandemicSemantic proximity Read ↗

An Open, Non-Randomised, 1/2 Phase Study on the Safety, Tolerability, and Immunogenicity of Single Dose 'Sputnik Light' Vaccine for Prevention of Coronavirus Infection in Healthy AdultsSemantic proximity Read ↗

Should the world collaborate imminently to develop neglected live‐attenuated vaccines for COVID‐19?Semantic proximity Read ↗

An Overview of Vaccine Development for COVID-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.